drug prices

On Sunday, President Donald Trump vowed to slash prescription drug prices through a sweeping executive order. What Happened: Trump took to Truth Social and announced plans to sign a new executive order. Under what he called a "most favored nation" pricing policy, the President said the executive...

Robert F. Kennedy Jr., President Donald Trump's pick for health secretary, addressed a wide range of medical-related topics on Wednesday during a confirmation hearing with the Senate Finance Committee. While Kennedy’s tone in each back-and-forth varied, depending on the senator, it was...

CVS Health Inc’s (NYSE:CVS) subsidiary, Aetna Inc., has filed a lawsuit against more than 20 generic drug manufacturers. The lawsuit alleges a coordinated scheme to fix prices, allocate markets, and stifle competition. The result was a significant overcharge for essential medications....

On Wednesday, the U.S. Department of Health and Human Services (HHS), working via the Centers for Medicare & Medicaid Services (CMS), released final guidance for the second cycle of the Medicare Drug Price Negotiation Program. This initiative aims to provide lower drug prices starting in 2026...

The Biden administration has disclosed the prices for the first ten prescription drugs that have been negotiated between Medicare and drug manufacturers. This significant step is part of an effort to make expensive medications more affordable for older Americans. What Happened: The announcement,...

President Donald Trump signed an executive order Sunday that aims to lower prescription drug prices in the United States for certain drugs by linking them to those paid by other developed countries. What Happened: The executive order mandates that for Medicare Part B and Part D prescription...

Health and Human Services Secretary Alex Azar and the Food and Drug Administration announced Wednesday that the Trump administration has dropped a long-standing resistance to importing drugs and outlined a plan that could eventually allow the importation of some cheaper prescription drugs from...

The Trump administration will no longer proceed with a large-scale overhaul of the drug-rebate industry. What Happened Pharmacy benefit managers (PBMs) negotiate a drug discount on behalf of health insurers and collect a commission for themselves as profit. Critics of the system argued it gives...

A U.S. federal judge ruled against a proposal that pharmaceutical companies need to disclose wholesale prices for their products in T.V. advertising, Reuters reported. What Happened The U.S. Department of Health and Human Services Secretary Alex Azar disclosed a new rule in early May which would...

The upward trajectory of prescription drug prices in the U.S. has drawn the ire of lawmakers. Prices of drugs are staggeringly high in the U.S. when compared to other developed countries such as Japan and in Europe. House lawmakers are discussing a plan that could work to curb high...

When anger over EpiPen pricing erupted in 2016, generic drugmaker Mylan NV (NASDAQ: MYL) was villainized.  The price of the autoinjector used for severe allergic reactions was hiked by about 500 percent between 2007 and 2016.  Both Democrats and Republicans came out strongly against...

The Food and Drug Administration announced Monday it would publish correspondence with drug manufacturers accused of abusing agency standards to foil generic competitors. Height Capital Markets considers the public censuring indicative of a broader federal strategy to pressure industry change....

President Donald Trump has nominated Alex Azar, a former pharmaceutical executive, to run the Department of Health and Human Services. What You Need To Know The Department of Health and Human Services is a cabinet-level department of the U.S. federal government with a mission of protecting...

As was widely documented, the healthcare sector languished last year thanks in large part to presidential election rhetoric in which both candidates excoriated biotechnology and pharmaceuticals for high drug prices. The Health Care SPDR (ETF) (NYSE: XLV), the largest healthcare exchange-traded fund...

President Donald Trump said Tuesday that drug prices are "astronomical" and much needed change needs to be implemented. His comments come at a time when he hosted drug makers at the White House and are also consistent with promises he made both during and after the campaign trail....